Cero Therapeutics

CERo Therapeutics, Inc. is an emerging cellular immunotherapy company. It is expanding its arsenal of engineered cell therapies to create a new class of innovative drugs for cancer patients. Leveraging insights into cellular clearance and molecular immunology, cells are engineered to engage novel and complementary cell elimination pathways, enabling deeper and more durable clinical responses. We rationally integrate engineered cells with drugs targeting precisely defined molecular targets to generate powerful therapeutic synergy.